ClinicalTrials.Veeva

Menu

Prone Positioning for Invasively Ventilated Patients With COVID-19 Registry (PROVENT-C19)

S

St. Bortolo Hospital

Status

Unknown

Conditions

COVID-19 Pneumonia

Treatments

Procedure: Prone Position

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

SARS-CoV-2 infection is characterized mainly by moderate/severe pneumonia associated with progressive endothelial damage and coagulopathy. Acute respiratory failure among COVID-19 occurs in 42% of patients with COVID-19 pneumonia, and 61-81% of patients requiring intensive care . Among the suggested treatments for the management of ARDS patients, prone position (PP) can be used as an adjuvant therapy for improving ventilation in these patients, as recommended in the Surviving Sepsis Campaign COVID-19 guidelines. Nevertheless, no data is currently available on application and feasibility of PP in invasively ventilated patients with COVID-19 on their outcomes.

Enrollment

1,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Laboratory-confirmed COVID-19 infection
  • Prone positioning in patients admitted to ICU undergoing invasive Mechanical Ventilation

Exclusion criteria

  • Bedsides contraindications to the Prone Positioning and patients in PP but undergoing Non- invasive ventilation should be excluded.

Trial design

1,000 participants in 1 patient group

Critically ill patients with COVID-19
Description:
n centres that obtained IRB approval for this prospective study, all critically ill adult patients (\>18yrs) undergoing PP - that are homogeneous in terms of both clinical and treatment characteristics - will be prospectively observed.
Treatment:
Procedure: Prone Position

Trial contacts and locations

1

Loading...

Central trial contact

Silvia De Rosa, MD; Paolo Navalesi, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems